Altered monocyte-derived dendritic cell function in patients on hemodialysis: a culprit for underlying impaired immune responses

Background Patients with end-stage renal disease (ESRD) are known to have impaired immune function. Dendritic cells (DCs) are the major antigen-presenting cells that initiate primary immune responses, linking innate and adaptive immunity. Although suboptimal immune responses to vaccination, as frequ...

Full description

Saved in:
Bibliographic Details
Published in:Clinical and experimental nephrology 2011-08, Vol.15 (4), p.546-553
Main Authors: Choi, Hye Min, Woo, Young Seok, Kim, Myung Gyu, Jo, Sang-Kyung, Cho, Won Yong, Kim, Hyoung Kyu
Format: Article
Language:English
Subjects:
Adult
Cell Differentiation
Cell Proliferation
Cell Survival
Cytokines
Dendritic Cells - immunology
Humans
Interleukin-6 - biosynthesis
Kidney Failure, Chronic - immunology
Kidney Failure, Chronic - physiopathology
Kidney Failure, Chronic - therapy
Medicine
Medicine & Public Health
Middle Aged
Monocytes - immunology
Nephrology
Original Article
Renal Dialysis - adverse effects
T-Lymphocytes - cytology
Urology
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Background Patients with end-stage renal disease (ESRD) are known to have impaired immune function. Dendritic cells (DCs) are the major antigen-presenting cells that initiate primary immune responses, linking innate and adaptive immunity. Although suboptimal immune responses to vaccination, as frequently observed in ESRD patients, might suggest the presence of impaired DC function, the precise nature of altered DC function is not fully understood. Methods In the current study, we compared the maturation status, viability, and function of monocyte-derived DCs (moDCs) of patients on hemodialysis (HD) with healthy controls. Results Surface expression of major histocompatibility complex class II, CD83, and CD86, and chemokine receptor CCR7 in moDCs was not different between HD patients and healthy controls. No significant difference was detected in the viability of moDCs determined by expression of annexin V and propidium iodide between two groups. However, moDCs from HD patients produced significantly higher amounts of IL-6 when stimulated by cytokine cocktails compared to healthy controls. In addition, mature moDCs from HD patients showed significantly enhanced allogeneic T-cell proliferation compared to healthy controls. Conclusions Our data demonstrate aberrant DC function in HD patients and suggest that this might contribute to impaired immune responses.
ISSN:1342-1751
1437-7799
DOI:10.1007/s10157-011-0424-2